Skip to content
Roboearth – Lifestyle
Author:
NUCLIDIUM AG
NUCLIDIUM Announces First Patient Imaged in Phase 2 Study Evaluating 61Cu-NU101 Diagnostic in Patients with Metastatic Prostate Cancer
October 8, 2026
NUCLIDIUM Announces Closing of Series B Extension Bringing Total Round to CHF 105 Million
May 27, 2026